Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

WuXi Biologics Plans Big Increase in Manufacturing Capacity

publication date: May 25, 2018

Over the past month, WuXi Biologics has announced three new manufacturing plants, two of them outside of China -- the first time it has located manufacturing plants in a foreign country. The new facilities represent substantial investments: $390 million for the Ireland plant, $240 million for Shijiazhuang (northern China) and $60 million in Singapore. WuXi completed its first biologics plant in 2012 in Wuxi City, which remained its only manufacturing facility until last year. By 2022, when all its announced facilities are expected to be GMP certified, WuXi will have ten plants operating with a total capacity of 222,700 liters annually, up from zero production capacity in 2011. More details....

Stock Symbol: (HK: 2269)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital